203 related articles for article (PubMed ID: 33542384)
1. Evaluation of quasi-static and dynamic nanomechanical properties of bone-metastatic breast cancer cells using a nanoclay cancer testbed.
Kar S; Katti DR; Katti KS
Sci Rep; 2021 Feb; 11(1):3096. PubMed ID: 33542384
[TBL] [Abstract][Full Text] [Related]
2. Mechanobiological evaluation of prostate cancer metastasis to bone using an in vitro prostate cancer testbed.
Molla MS; Katti DR; Katti KS
J Biomech; 2021 Jan; 114():110142. PubMed ID: 33290947
[TBL] [Abstract][Full Text] [Related]
3. Tissue-engineered nanoclay-based 3D in vitro breast cancer model for studying breast cancer metastasis to bone.
Kar S; Molla MS; Katti DR; Katti KS
J Tissue Eng Regen Med; 2019 Feb; 13(2):119-130. PubMed ID: 30466156
[TBL] [Abstract][Full Text] [Related]
4. Mechanical properties of cancer cytoskeleton depend on actin filaments to microtubules content: investigating different grades of colon cancer cell lines.
Pachenari M; Seyedpour SM; Janmaleki M; Babazadeh Shayan S; Taranejoo S; Hosseinkhani H
J Biomech; 2014 Jan; 47(2):373-9. PubMed ID: 24315289
[TBL] [Abstract][Full Text] [Related]
5. AFM nanoindentation detection of the elastic modulus of tongue squamous carcinoma cells with different metastatic potentials.
Zhou Z; Zheng C; Li S; Zhou X; Liu Z; He Q; Zhang N; Ngan A; Tang B; Wang A
Nanomedicine; 2013 Oct; 9(7):864-74. PubMed ID: 23579203
[TBL] [Abstract][Full Text] [Related]
6. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro.
Yoneda T; Williams PJ; Hiraga T; Niewolna M; Nishimura R
J Bone Miner Res; 2001 Aug; 16(8):1486-95. PubMed ID: 11499871
[TBL] [Abstract][Full Text] [Related]
7. Cytoskeletal Actin Structure in Osteosarcoma Cells Determines Metastatic Phenotype via Regulating Cell Stiffness, Migration, and Transmigration.
Kita K; Asanuma K; Okamoto T; Kawamoto E; Nakamura K; Hagi T; Nakamura T; Shimaoka M; Sudo A
Curr Issues Mol Biol; 2021 Sep; 43(3):1255-1266. PubMed ID: 34698103
[TBL] [Abstract][Full Text] [Related]
8. Small size fullerenol nanoparticles suppress lung metastasis of breast cancer cell by disrupting actin dynamics.
Qin Y; Chen K; Gu W; Dong X; Lei R; Chang Y; Bai X; Xia S; Zeng L; Zhang J; Ma S; Li J; Li S; Xing G
J Nanobiotechnology; 2018 Jun; 16(1):54. PubMed ID: 29935539
[TBL] [Abstract][Full Text] [Related]
9. Bone interface modulates drug resistance in breast cancer bone metastasis.
Kar S; Katti DR; Katti KS
Colloids Surf B Biointerfaces; 2020 Nov; 195():111224. PubMed ID: 32634713
[TBL] [Abstract][Full Text] [Related]
10. [Whole-body bone scintigraphy in the diagnosis and follow-up of the evolution of breast cancer].
Muşat E; Stefănescu C; Rusu V
Rev Med Chir Soc Med Nat Iasi; 1999; 103(1-2):163-9. PubMed ID: 10756905
[TBL] [Abstract][Full Text] [Related]
11. Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer.
Yi B; Williams PJ; Niewolna M; Wang Y; Yoneda T
Cancer Res; 2002 Feb; 62(3):917-23. PubMed ID: 11830552
[TBL] [Abstract][Full Text] [Related]
12. Animal Models of Breast Cancer Bone Metastasis.
Tulotta C; Groenewoud A; Snaar-Jagalska BE; Ottewell P
Methods Mol Biol; 2019; 1914():309-330. PubMed ID: 30729473
[TBL] [Abstract][Full Text] [Related]
13. Asperolide A prevents bone metastatic breast cancer via the PI3K/AKT/mTOR/c-Fos/NFATc1 signaling pathway.
Jiang W; Rixiati Y; Huang H; Shi Y; Huang C; Jiao B
Cancer Med; 2020 Nov; 9(21):8173-8185. PubMed ID: 32976685
[TBL] [Abstract][Full Text] [Related]
14. Wnt/β-Catenin Signaling Pathway Regulates Osteogenesis for Breast Cancer Bone Metastasis: Experiments in an
Kar S; Jasuja H; Katti DR; Katti KS
ACS Biomater Sci Eng; 2020 May; 6(5):2600-2611. PubMed ID: 33463270
[TBL] [Abstract][Full Text] [Related]
15. High expression of FBP17 in invasive breast cancer cells promotes invadopodia formation.
Suman P; Mishra S; Chander H
Med Oncol; 2018 Apr; 35(5):71. PubMed ID: 29651632
[TBL] [Abstract][Full Text] [Related]
16. Experimental bone metastasis model of the oral and maxillofacial region.
Sasaki A; Yoneda T; Terakado N; Alcalde RE; Suzuki A; Matsumura T
Anticancer Res; 1998; 18(3A):1579-84. PubMed ID: 9673373
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the elastic Young's modulus and cytotoxicity variations in fibroblasts exposed to carbon-based nanomaterials.
Pastrana HF; Cartagena-Rivera AX; Raman A; Ávila A
J Nanobiotechnology; 2019 Feb; 17(1):32. PubMed ID: 30797235
[TBL] [Abstract][Full Text] [Related]
18. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
[TBL] [Abstract][Full Text] [Related]
19. Osteoblastic metastases from breast carcinoma with false-negative bone scan.
Munk PL; Poon PY; O'Connell JX; Janzen D; Coupland D; Kwong JS; Gelmon K; Worsley D
Skeletal Radiol; 1997 Jul; 26(7):434-7. PubMed ID: 9259104
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer and bone metastases: the association of axial skeleton MRI findings with skeletal-related events and survival.
van der Pol CB; Schweitzer ME; Di Primio G; Sampaio ML; Kielar A; Clemons M; Jaberi A
Breast Cancer Res Treat; 2014 Aug; 146(3):583-9. PubMed ID: 25007963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
